Johnson & Johnson MedTech acquires heart implant company Laminar for $400m
The deal, which will also include potential clinical and regulatory milestone payments in 2024 and beyond, will see Laminar join J&J’s Biosense Webster division.

The deal, which will also include potential clinical and regulatory milestone payments in 2024 and beyond, will see Laminar join J&J’s Biosense Webster division.
The tool acts as an insurance policy for prospective clinical trials.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
GE HealthCare rolls out new AI platform for breast cancer imaging
AWAK obtains breakthrough device designation for KDPP tool
Philips introduces new AI-enabled solutions for healthcare providers
HOPPR introduces new foundation model for medical imaging